1. Introduction {#sec1}
===============

Solar ultraviolet (UV)-induced skin tanning is known to be associated with epidermal genotoxic stress \[[@bib1], [@bib2], [@bib3]\]. After initial genomic photodamage associated with cyclobutane pyrimidine dimer (CPD) formation, melanogenesis occurs downstream of p53-dependent proopiomelanocortin (*POMC)* expression and paracrine signaling through α-MSH that activates melanocortin (MC1R) on melanocytes, followed by melanin production and redistribution to solar UV-exposed keratinocytes \[[@bib1],[@bib4],[@bib5]\]. Chemical tanning is widely regarded as a safe alternative to solar UV-induced skin tanning, but the cutaneous biology impacted by sunless tanning remains largely unexplored \[[@bib6], [@bib7], [@bib8]\]. Discovered in the context of nutritional interventions examining pediatric glycogen storage disease with systemic administration of triose sugars, chemical tanning is now a standard cosmetic intervention used by large numbers of consumers worldwide \[[@bib8], [@bib9], [@bib10]\].

Chemical tanning is based on the formation of melanin-mimetic cutaneous pigments (referred to as 'melanoidins') from spontaneous amino-carbonyl ('glycation') reactions between epidermal amino acid/protein components and reactive sugars of the ketose family including the glycolytic triose DHA and the tetrose erythrulose \[[@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12]\]. Interestingly, previous research has investigated glycation and metabolic impact of DHA and its glycolytic phospho-metabolite dihydroxyacetone phosphate \[[@bib13],[@bib14]\]. Glycation reactions are associated with the formation of posttranslational protein modifications referred to as advanced glycation end products (AGEs) \[[@bib15],[@bib16]\]. Moreover, the chemistry leading to AGE formation involves reactive intermediates such as reactive carbonyl (e.g. glyoxal and methylglyoxal) and oxygen species (ROS) \[[@bib17],[@bib18]\]. Previous research has investigated the involvement of glycation reactions and formation of cutaneous AGEs in the context of diabetic wound healing, solar photodamage, photocarcinogenesis, and chronological aging \[[@bib19], [@bib20], [@bib21], [@bib22]\]. Moreover, chemical crosslinking of skin extracellular matrix proteins and photosensitization activity of specific AGE-chromophores have been observed in human skin, and specific protein-bound AGEs \[e.g. N^ε^-carboxymethyl-[l]{.smallcaps}-lysine (CML) and N^ε^-carboxyethyl-[l]{.smallcaps}-lysine (CEL)\] stimulate signaling through specialized receptors including r*eceptor for advanced glycation end products* (RAGE) and *toll-like receptor 4* (TLR4) that trigger inflammatory signaling upon ligand binding \[[@bib20],[@bib23], [@bib24], [@bib25], [@bib26]\].

After topical application, chemical tanning agents are thought to be confined to the stratum corneum without affecting structure and function of viable epidermal layers \[[@bib27]\]. However, safety concerns have been raised based on pharmacokinetic data demonstrating (*i*) DHA skin penetration after topical application, (*ii*) detection of glycation-associated formation of free radicals and AGEs, and (*iii*) induction of genotoxic stress \[[@bib6],[@bib12]\].

Here, we have examined the cutaneous effects of acute DHA exposure employing cultured human HaCaT keratinocytes, organotypic epidermal reconstructs, and SKH-1 hairless mouse skin, profiled by gene expression array analysis and immunodetection. Taken together, our prototype data document that topical DHA application induces cutaneous stress response signaling and gene expression that occur within minutes of exposure. Given the worldwide use of chemical tanners including DHA in consumer products these findings deserve further molecular exploration in relevant model systems and live human skin.

2. Materials and methods {#sec2}
========================

**Chemicals:** All chemicals were purchased from Sigma Aldrich (St. Louis, MO, USA) including dihydroxyacetone (D107204) and glycerol (G5516).

**Human skin cell culture:** Human immortalized keratinocytes (HaCaT) and malignant A375 melanoma cells were purchased from ATCC (Manassas, VA, USA) and maintained according to the manufacturer\'s instructions. In brief, both HaCaT and A375 cells were cultured in DMEM medium (Corning, Manassas, VA) or RPMI (ATCC), respectively, supplemented with 10% bovine calf serum (HyClone™ Laboratories, Logan, UT). Unless specified otherwise, DHA exposure was performed in PBS (instead of complete medium) in order to minimize the impact of indirect glycation reactions (e.g. DHA-modification of serum proteins that might confound cellular effects).

**CRISPR/Cas9-based engineering of *GLO1\_*KO A375 malignant melanoma cells:** Homozygous *GLO1* gene knock-out in human malignant A375 melanoma cells was performed using genetic engineering as published elsewhere \[[@bib28]\]. Briefly, double strand breaks were generated on both sides of exon 2 (chromosome 6, positions: 38,687,313 bp; 38,685,738 bp) with guide CRISPR RNAs (5′-ACCCTCATGGACCAATCAGT-3′ and 5′-TGATCATAGGTGTATACGAG-3′). Parental cells were transfected with Cas9 protein, crRNAs, and *trans*-activating crRNA (Integrated DNA Technologies, San Diego, CA) using the Lipofectamine RNAiMAX reagent (Thermo Fisher Scientific, Waltham, MA). Next, single cells were deposited in 96-well plates and once single cell colonies expanded (after approximately three weeks), individual clones were screened by PCR. Clones that were negative for a sequence inside the targeted deletion and negative for the undeleted chromosomal sequences but positive for ligation-junction fragment were scored as potentially homozygous for *GLO1* exon 2 deletion. Absence of *GLO1* expression was confirmed by single RT-qPCR, immunoblot, and enzymatic activity assays \[[@bib29]\].

**Human epidermal reconstructs:** Before treatment, refrigerated epidermal reconstructs (EPI-200, 9 mm diameter; MatTek, Corp., Ashland, MA) were equilibrated in fresh growth medium (0.9 mL; EPI-200-ASY media per well, 1 h), following our standard procedures for maintenance and treatment as published before \[[@bib30], [@bib31], [@bib32]\]. Briefly, stratum corneum of air exposed reconstructs was treated with topical DHA \[100 μL; 10% in Vanicream™ (Pharmaceutical Specialties, Inc., Rochester, MN) or Vanicream™ carrier only; 6 h exposure time, 37 °C; 5% CO~2~\]. Following exposure, carrier (with or without DHA) was removed using a cotton swab. Digital colorimetry assessing DHA-induced tanning was performed using the Image Studio™ Lite quantification software version 5.2 (LI-COR Biosciences, Lincoln, NE). The epidermal reconstruct was then processed for (*i*) RNA extraction using the RNeasy Mini kit (Qiagen, Germantown, MD) or (*ii*) immunohistochemical analysis as described before \[[@bib30], [@bib31], [@bib32]\].

**Cell viability analysis by flow cytometry:** Cells were treated with DHA (≤50 mM; 1 h in PBS), followed by culture in fresh growth medium (≤24 h). Cell viability was then determined using flow cytometric analysis of annexinV (AV)-propidium iodide (PI) stained cells using an apoptosis detection kit (APO-AF, Sigma, St. Louis, MO) according to the manufacturer\'s specifications as published before \[[@bib33]\].

**Cell proliferation assay:** Cells (5000 per 35 mm dish) were seeded; the following day (d 0), cells were treated with DHA (≤50 mM; 1 h in PBS), followed by culture in fresh growth medium (72 h). Cells were counted (d0 and d3) using a Z2 analyzer (Beckman Coulter, Fullerton, CA, USA).

**Cell cycle analysis:** Cell cycle analysis was performed treating cells as detailed for proliferation analysis. After 48 h, cells were harvested and fixed in ethanol (100%). Cell pellets were then incubated \[37 °C, 30 min; Ribonuclease A (1 mg/mL) with propidium iodide (4 mg/mL) in PBS\] and then analyzed by flow cytometry. Cellular DNA content was analyzed using ModFit LT software, version 5.0 (Verity, Topsham, ME) \[[@bib34]\].

**Human Stress & Toxicity PathwayFinder RT**^**2**^ **Profiler**^**TM**^ **gene expression array analysis:** After DHA treatment, total mRNA from cultured HaCaT keratinocytes (200,000 in 35 mm dish format) or epidermal reconstructs was prepared using the RNeasy Mini kit (Qiagen, Valencia, CA) following our published standard procedures. Reverse transcription was then performed using the RT^2^ First Strand kit (Qiagen) from 500 ng total RNA. For gene expression array analysis, the human Stress & Toxicity PathwayFinder RT^2^ Profiler™ technology (Qiagen), assessing expression of 84 stress response-related genes, was used as published before \[[@bib30], [@bib31], [@bib32], [@bib33]\]. Quantitative PCR was run using the following conditions: 95 °C (10 min), followed by 40 cycles at 95 °C (15 s) alternating with 60 °C (1 min) (Applied Biosystems, Carlsbad, CA). Gene-specific products were normalized to a group of 5 housekeeping genes (*ACTB*, *B2M*, *GAPDH*, *HPRT1*, *RPLP0)* and quantified using the comparative ΔΔCt method (ABI Prism 7500 sequence detection system user guide). Expression values were averaged across at least three independent array experiments, and standard deviation was calculated for graphing and statistical analysis as published before.

**Individual RT-qPCR analysis:** Total cellular mRNA was isolated using the Qiagen RNeasy Mini Kit (Qiagen, Gaithersburg, MD) according to the manufacturer\'s protocol. Human primer probes \[*GLO1* (Hs_02861567_m1), *HMOX1* (Hs00157965_m1), *HSPA1A* (Hs00359163_s1), *HSPA6* (Hs00275682_s1), *RSP18 (*housekeeper; Hs_01375212_g1)\], were obtained from Thermo Fisher Scientific, Waltham, MA. After cDNA synthesis, quantitative PCR reactions were performed as follows: 10 min (95 °C) followed by 15 s (95 °C), 1 min (60 °C), 40 cycles, using the ABI7500 Real-Time PCR System (Applied Biosystems, Foster City, CA). Amplification plots were generated, and Ct values were recorded as published before \[[@bib33]\].

**Immunoblot analysis:** Detection of proteins by immunoblot analysis was conducted using the following primary antibodies: Nrf2 (13032, Santa Cruz Biotechnology, Santa Cruz, CA), HO-1 (5853, Cell Signaling, Danvers, MA), αβ-crystallin (45844, Cell Signaling), HSP70B' (ADI-SPA-754, Enzo Life Sciences, Farmingdale, NY), β-actin (A4700, Sigma), phospho-p38 (9211, Cell Signaling), total p38 (9212, Cell Signaling), phospho-eIf2α (9721, Cell Signaling), total eIF2α (9722, Cell Signaling), phospho-HSP27 \[serine 15 (ADI-SPA-525), serine 78 (ADI-SPA-523), serine 82 (ADI-SPA-524)\], total HSP27 (ADI-SPA-803, Enzo Life Sciences), phospho-ERK1/2 (5726, Cell Signaling), total ERK1/2 (4696, Cell Signaling) and GLO1 (ab96032, Abcam, Cambridge, MA). The secondary antibodies used were goat anti-mouse (115-035-146, Jackson Immunological Research, West Grove, PA) or anti-rabbit (111-035-144, Jackson Immunological Research), followed by enhanced chemiluminescent detection (32106, ThermoFisher Scientific, Waltham, MA). For quantification of immunoblots, digital image analysis was performed using Image Studio™ Lite quantification software (LI-COR Biosciences, Lincoln, NE).

**Detection of intracellular oxidative stress:** HaCaT cells were exposed to DHA (≤40 mM; \< 2 h in PBS). Fresh medium was supplemented with 2′,7′-dichlorodihydrofluorescein-diacetate (DCF) according to a previously published method \[[@bib30], [@bib31], [@bib32], [@bib33]\]. Cells were then harvested and analyzed by flow cytometric detection of DCF-stained cells.

**Comet assay (alkaline single cell gel electrophoresis):** HaCaT cells were treated with DHA (20 mM; 1 h in PBS) followed by cell lysis and alkaline comet assay (Trevigen, Gaithersburg, MD) with DAPI fluorescence microscopy as published before. In addition, the Fpg-FLARE assay kit (Trevigen, Gaithersburg, MD) was utilized for detection of oxidative DNA base damage as published before \[[@bib32]\].

**Detection of γ-H2AX (S139):** Following a published standard procedure, HaCaTs were incubated with DHA (≤40 mM; 1 h in PBS). Cells were then washed with PBS and fixed (4% formalin, 15 min, room temperature). After permeabilization (90% methanol in PBS on ice), cells were stained using γ-H2AX Alexa 488-conjugate antibody (1:50; 0.5% BSA in PBS, Cell Signaling, Danvers, MA) followed by PBS-wash and flow cytometric analysis \[[@bib34]\].

**QuARKMod (Quantitative Analysis and Discovery of Lysine and Arginine Modifications) analysis for posttranslational modification quantitation via LC-MS/MS:** Cells were exposed to DHA (≤20 mM, 1 h in PBS; n = 6) and replenished/cultured under growth medium for an additional 5 h. After cell harvest, total protein extraction, and BCA-assay based protein quantification, lysine and arginine glycation-adducts were quantified (per 100 μg) as described earlier \[[@bib35]\]. Briefly, 50 mM ammonium bicarbonate, pH 8.0 (60 μL), was added to each protein pellet followed by the addition of an internal standard mix (10 μL, see table below) and 1 μg of sequencing-grade trypsin (Promega, 10 μL). Proteins were then digested overnight (37 °C). After incubation, trypsin was denatured via heating (95 °C; 10 min). After the samples returned to room temperature, 15 μg of aminopeptidase M (Millipore, 10 μL) was added to each sample and incubated overnight at 37 °C. Following digestion, 10 μL of a solution containing heptafluorobutyric acid (HFBA) and water (1:1) was added to each sample. Insoluble debris was removed via centrifugation at 14,000×*g* for 10 min 10 μL of the supernatant was then chromatographed \[Shimadzu LC system; 150 × 2.1 mm, 3.5 μm particle diameter Eclipse XDB-C8 column (Agilent, Santa Clara, CA); flow rate: 0.425 mL/min; mobile phase A: 10 mM HFBA in water; mobile phase B: 10 mM HFBA in acetonitrile\]. The following gradient was used: 0.5 min, 5% B; 8 min, 50% B; 8.5 min, 80% B; 9 min 80% B; 9.5 min, 5% B. Scheduled multiple reaction monitoring (MRM) was conducted in positive-ion mode using an AB SCIEX 4500 QTRAP. MRM detection window was 50 s with a target scan time of 0.75 s. The following parameters were used for detection:SpeciesQ1 (*m*/*z*)Q3 (*m*/*z*)Time (min)CE (V)Lys147.184.14.729^13^C~6~^15^N~2~ Lys155.190.14.729Arg175.170.15.047^13^C~6~^15^N~4~ Arg185.175.15.047Leu132.186.15.417^13^C~6~^15^N Leu139.193.15.417MG-H1229.270.15.55313C-MG-H1230.270.15.553CEA247.270.15.455^13^C-CEA248.270.15.455LactoylLys219.284.13.341CEL219.284.14.741CEL-d~4~223.288.14.741

Analytes were quantified using their respective internal standards. LactoylLys was quantified against CEL-d~4~. Lysine and arginine analytes were measured to ensure consistency and minimal changes of amino acids between samples. All samples were corrected with enzyme controls and normalized to leucine \[[@bib35]\].

**GLO1 enzymatic activity assay:** Glyoxalase I specific enzymatic activity in melanoma A375 cell cytosolic fractions was analyzed using a colorimetric assay kit (Abcam, Cambridge, UK) according to manufacturer\'s instructions \[[@bib29]\]. Briefly, pelleted cells (approximately 2 × 10^6^) were homogenized with 300 μL of ice-cold Glo I Assay Buffer containing protease inhibitor PMSF and centrifuged (12,000 g; 4 °C; 10 min). Supernatant cytosolic fractions were analyzed for protein content (Pierce™ BCA Protein Assay Kit, Thermo Fisher Scientific, Waltham, MA); equal amounts (10 μg protein) were mixed with substrate and then examined for enzymatic activity by measuring absorbance at 240 nm in kinetic mode (room temperature; 10--20 min).

**Irradiation with solar simulated UV light (SSL):** A KW large area light source solar simulator, model 91293, from Oriel Corp. (Stratford, CT) was used, equipped with a 1000 W xenon arc lamp power supply, model 68920, and a VIS-IR band pass blocking filter plus either an atmospheric attenuation filter (output 290--400 nm plus residual 650--800 nm for solar simulated light) \[[@bib30], [@bib31], [@bib32], [@bib33],[@bib36]\]. The output was quantified using a dosimeter from International Light Inc. (Newburyport, MA), model I L1700, with an SED240 detector for UVB (range 265--310 nm, peak at 285 nm) or a SED033 detector for UVA (range 315--390 nm peak 365 nm) at a distance of 365 mm from the source, which was used for all experiments. At 365 mm from the source, total solar UV intensity was 7.60 mJ/cm^2^ s (UVA) and 0.41 mJ/cm^2^ s (UVB).

**Immunohistochemistry:** Following DHA treatment of mouse skin and epidermal reconstructs, immunohistochemical detection was performed as follows: Tissues were collected, fixed in NBF (10%), and embedded in paraffin. Following deparaffinization, hydration, and antigen retrieval the following primary antibodies were used: HO-1 (1:250, 13248, abcam), total HSP27 (1:500, ADI-SPA-803, Enzo Life Sciences), phospho-HSP27 (S78) (1:100, ADI-SPA-523, Enzo Life Sciences). Moreover, for detection of N^ε^-carboxyethyl-[l]{.smallcaps}-lysine (CEL; 1:3000; 30917, abcam), an antibody known to equally recognize N^ε^-carboxymethyl-[l]{.smallcaps}-lysine (CML) and CEL was used \[[@bib37],[@bib38]\]. After overnight incubation, secondary antibody was applied followed by streptavidin/horseradish peroxidase incubation (RTU PK7200, Vector Laboratories, Burlingame, CA), development using diaminobenzidine/hydrogen peroxide (Vectastain ABC, SK-4103, Vector Laboratories), and hematoxylin counterstaining. Negative controls were performed on each run substituting the primary antibody with mouse IgG1 (X0931, Agilent/DAKO, Santa Clara, CA). Images were obtained with an Olympus microscope (BX50 L98-029) and camera (DP72, Center Valley, PA) using the cellSens program.

**Mouse experiment:** SKH-1 Elite™ mice (6--8 weeks old; n ≥ 3 per group) were obtained from Charles River Laboratories (Stain code 477) and maintained at the University of Arizona, according to an approved protocol by the Institutional Animal Care and Use Committee (IACUC). 72 h after topical treatment \[DHA (10% in Vanicream™) or carrier only; 200 μL\], skin was processed for immunohistochemical analysis according to published procedures \[[@bib39]\].

**Statistical analysis:** For every data point presented, at least three independent experiments were conducted and analyzed \[[@bib39]\]. Unless indicated otherwise, statistical significance was calculated employing the Student\'s two-tailed *t*-test, utilizing Excel (Microsoft®, Redmond, WA). The level of statistical significance was marked as follows: \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

3. Results {#sec3}
==========

Dose response relationship of DHA-induced impairment of cell viability, proliferation, and cell cycle progression in human HaCaT keratinocytes.

Following previous studies that have addressed the potential cytotoxicity of DHA on human skin, we first determined the dose response relationship of DHA-induced impairment of cell viability, proliferation, and cell cycle progression as assessed in HaCaT keratinocytes \[[@bib12],[@bib40]\]. Indeed, significant impairment of cell viability was observed only upon exposure to high DHA concentrations (≥40 mM; [Fig. 1](#fig1){ref-type="fig"}a). Likewise, inhibition of cell proliferation occurred as a result of exposure to high DHA concentrations (≥20 mM; [Fig. 1](#fig1){ref-type="fig"}b). At 20 mM DHA, a concentration that did not interfere with cell viability, half-maximal inhibition of proliferation was observed. Next, in order to further explore the role of cell cycle in the causation of inhibited proliferation, we performed flow cytometric analysis of cell cycle progression as a function of DHA exposure ([Fig. 1](#fig1){ref-type="fig"}c and d). Strikingly, only at higher concentrations (≥30 mM) DHA treatment caused a significant increase in cells in G2/M phase of the cell cycle. Taken together, these initial dose response relationship experiments indicate a range of DHA concentration (≤20 mM) that does not interfere with cell viability and is devoid of adverse effects on cell cycle progression. Thus, this concentration range was chosen for execution of our subsequent experiments to define the early cellular stress response displayed by cultured human keratinocytes subjected to short term DHA exposure.Fig. 1**DHA attenuates cell viability, proliferation and cell cycle progression in human keratinocytes.** (a) Impairment of cellular viability in response to acute DHA exposure (≤50 mM; 1 h in PBS followed by 24 h in growth medium) as assessed by flow cytometry (annexin V-PI staining). Numbers in quadrants indicate viable cells (AV-negative, PI-negative) in percent of total gated cells; bar graph summarizes numerical values (mean ± SD). (b) DHA-induced impairment of cellular proliferation \[≤ 50 mM, continuous exposure (72 h) in growth medium; n = 3\]. (c) DHA-induced cell cycle alteration \[≤ 30 mM, continuous exposure (48 h) in growth medium\] as assessed by flow cytometry of PI-stained cells; bar graph summarizes numerical values (mean ± SEM, n = 3). (d) Representative cell cycle histograms per treatment group.Fig. 1

Expression array analysis reveals stress response gene expression in human HaCaT keratinocytes exposed to DHA.

Next, to determine keratinocyte stress response gene expression elicited by DHA exposure (performed at concentrations that do not impair cell viability), we employed the Human Stress and Toxicity PathwayFinder™ PCR Array technology. Strikingly, acute exposure to DHA (1 h in PBS followed by 5 h culture in growth medium) caused a pronounced upregulation of stress response gene expression including genes encoding specific heat shock \[*CRYAB* (31-fold), *HSPA6* (22-fold), DNAJB4 (2-fold)\], oxidative stress \[*HMOX1* (6-fold)\], and DNA damage \[*XRCC2* (5-fold), ERCC3 (2-fold)\] response factors ([Fig. 2](#fig2){ref-type="fig"}a and b). Moreover, DHA treatment downregulated expression of genes encoding inflammatory chemokines \[*CCL3*, *CCL4*, *CCL21*\] and other mediators of inflammation and tissue remodeling \[*NOS2*, *NFKB1*, *GDF15*\] as well as members of the cytochrome P450 class \[*CYP2E1*, *CYP1A1*, *CYP7A1*\]. Also, independent RT-qPCR analysis confirmed DHA-induced upregulation of *HMOX1* encoding the antioxidant enzyme heme oxygenase-1 detectable as concentrations as low as 10 mM ([Fig. 2](#fig2){ref-type="fig"}c).Fig. 2**Array analysis reveals early stress response gene expression in human keratinocytes receiving acute DHA exposure.** (a) HaCaT keratinocytes underwent short term DHA exposure (20 mM; 1 h in PBS followed by 5 h in growth medium). Stress response gene expression was then assessed by RT^2^ Profiler™ Gene Expression Array analysis (volcano blot; p \< 0.05). (b) Table summarizes numerical values (n = 3, p \< 0.05). (c) Confirmatory single RT-qPCR analysis (*HMOX1*, mean ± SEM). (d) Immunoblot analysis profiling stress response protein expression (≤30 mM DHA, ≤ 24 h); bar graphs summarize densitometric analysis of antigens (mean ± SEM).Fig. 2

Next, in order to determine if DHA-induced gene expression changes were observable at the protein level, immunoblot analysis was performed ([Fig. 2](#fig2){ref-type="fig"}d). Indeed, upregulated cellular levels of heat shock proteins \[crystallin alpha B (encoded by *CRYAB*); HSP70B' encoded by *HSPA6*\], the DNA damage repair enzyme XRCC2 (encoded by *XRCC2*), and oxidative stress response factors including the transcription factor NRF2 and its target heme oxygenase-1 (HO-1 encoded by *HMOX1*) were detectable within 6 h of DHA exposure. Moreover, sustained upregulation of HO-1, CRYAB, and XRCC2 levels was confirmed by immunoblot analysis performed at 24 h after DHA treatment.

Taken together, these data indicate that acute DHA exposure at sublethal concentrations causes pronounced stress response gene expression observable at the mRNA and protein levels in cultured HaCaT keratinocytes.

DHA induces phosphoprotein-associated stress signaling in human HaCaT keratinocytes.

After analysis of DHA-induced gene expression changes detectable at the mRNA and protein levels, we then focused on immunodetection of DHA-induced phospho-protein signaling ([Fig. 3](#fig3){ref-type="fig"}). To this end, HaCaT keratinocytes were DHA-exposed (0--30 mM; 1 h in PBS), followed by immunoblot detection of stress protein phosphorylation, focusing on crucial components of (*i*) MAPK-, (*ii*) ER-, and (*iii*) heat shock-stress response pathways. Indeed, phosphorylation of ERK1/2-MAPK ([Fig. 3](#fig3){ref-type="fig"}a) was found to be responsive to DHA exposure. Likewise, p38-MAPK displayed a pronounced, dose-dependent increase in activational phosphorylation in response to DHA exposure ([Fig. 3](#fig3){ref-type="fig"}a), and time course analysis revealed p38 phosphorylation within 1 min exposure time ([Fig. 3](#fig3){ref-type="fig"}b). In the context of UV-induced cell stress, p38 is known to become activated and then phosphorylate small heat shock proteins (HSP27, αβ-crystallin, etc.) \[[@bib41],[@bib42]\]. Consistent with the phosphorylation of the established p38-MAPK downstream target HSP27 at three distinct sites (serine 15, 78, and 82)\], documented earlier to be responsive to environmental stressors including solar UV, we observed that HaCaT exposure to DHA (10 mM) caused pronounced HSP27-phosphorylation (S15, S78) detectable within 1 min exposure time ([Fig. 3](#fig3){ref-type="fig"}a and b). In addition, it was observed that DHA exposure causes pronounced induction of ER-stress response signaling as indicated by phosphorylation of eIF2α detectable within 1 min DHA exposure, an observation consistent with rapid induction of DHA induced protein translation blockade ([Fig. 3](#fig3){ref-type="fig"}a and b) \[[@bib43]\].Fig. 3Acute DHA exposure induces dose- and time-dependent phospho-protein stress signaling in human keratinocytes. Protein phosphorylation in response to acute DHA exposure was profiled by immunoblot analysis: (a) dose-response relationship (≤30 mM DHA in PBS; 1 h); (b) time course (20 mM DHA in PBS; ≤ 2 h); bar graphs summarize densitometric analysis of antigens (mean ± SEM).Fig. 3

Taken together, these data indicate that acute DHA exposure performed at dose-regimens that do not impair viability induce rapid and pronounced MAPK-, ER-, and heat shock-stress response signaling detectable at the mRNA and (phospho)-protein levels.

DHA induces AGE formation and cytotoxic glycation stress, antagonized by expression of the glycation defense enzyme glyoxalase 1 (encoded by *GLO1*).

Next, in order to explore the molecular nature of cellular stress imposed by DHA treatment in HaCaT keratinocytes ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}), we examined the occurrence of DHA-induced oxidative stress, as already suggested by DHA-upregulated expression of the antioxidant defense gene *HMOX1* ([Fig. 2](#fig2){ref-type="fig"}). Significant elevation of intracellular ROS levels (as assessed by DCF fluorescence-based flow cytometry) was observed only when HaCaT keratinocytes were exposed to high DHA concentrations (≥40 mM) ([Fig. 4](#fig4){ref-type="fig"}a), and similar results were observed when the reduced glutathione pool was examined using a luminescent luciferase-coupled assay (data not shown). Next, examination of DHA-induced genotoxic effects (as assessed by detection of γ-H2AX, an established marker of electrophilic DNA damage and double strand breaks) indicated significant elevation of γ-H2AX levels as detected by flow cytometry, again observable only at high DHA concentrations ([Fig. 4](#fig4){ref-type="fig"}b). Interestingly, alkaline single cell gel electrophoresis (comet analysis) assessing genotoxic consequences of DHA exposure did not reveal the occurrence of DHA-induced DNA damage, even if performed using the N-formylpyrimidine-glycosylase (Fpg) digestion method detecting oxidative DNA damage through cleavage at 8-oxo-dG sites ([Fig. 4](#fig4){ref-type="fig"}c).Fig. 4**Glycation stress and AGE-formation in DHA-exposed human keratinocytes.** (a) DHA-induced (≤40 mM, 2 h; mean ± SEM) intracellular oxidative stress as assessed by flow cytometric analysis of DCF-stained cells. (b) DHA-induced activation of DNA damage response as detected by flow cytometric analysis of γ-H2AX staining. (c) DHA-induced (20 mM) oxidative DNA damage as detected by comet assay with FPG-digestion for 8-oxo-dG detection \[mean comet tail moment ± SEM; representative images (left) with dot blot depiction of quantitative analysis (right)\]. (d) Glycerol-induced (≤30 mM; 1 h in PBS) phosphoprotein signaling as assessed by immunoblot analysis; bar graphs summarize densitometric analysis of antigens (mean ± SEM). (e) AGE-type posttranslational modification detected in total protein extracts from DHA-treated keratinocytes (≤20 mM, 1 h in PBS, followed by 5 h in growth medium, n = 6, mean ± SEM) by LC-MS/MS analysis. (f) DHA-modulation (≤20 mM) of *GLO1* mRNA expression in HaCaT keratinocytes determined by RT-qPCR. (g) *GLO1* mRNA expression in A375_WT and *GLO1*\_KO cells as determined by RT-qPCR; insert depicts representative immunoblot analysis of GLO1 protein levels. (h) GLO1 enzymatic activity compared between A375_WT and *GLO1*\_KO cells. (i) DHA-induced impairment of cell viability (A375_WT versus A375-*GLO1*\_KO) as determined in [Fig. 1](#fig1){ref-type="fig"}a; bar graph summarizes numerical values (mean ± SD).Fig. 4

Next, in order to explore the possibility that signaling responses observed in HaCaT keratinocytes may be attributable to compound-induced osmotic stress (as expected to occur as a result of exposure to millimolar sugar concentrations), analogous experimentation was performed using glycerol, the trihydroxy-alcohol analogue of the keto-triose sugar DHA, serving as molecular control devoid of tanning activity due to the absence of a glycation-active α-hydroxy-carbonyl moiety ([Fig. 4](#fig4){ref-type="fig"}d). Strikingly, it was observed that glycerol (employed at equimolar concentrations) did not elicit stress response signaling characteristic of DHA ([Fig. 3](#fig3){ref-type="fig"}), as evident from analogous phospho-protein immunoblot analysis examining responsiveness of p38, Hsp27, and eIF2α phospho-signaling ([Fig. 4](#fig4){ref-type="fig"}d).

Next, we examined the occurrence of glycation damage as a result of DHA exposure \[[@bib19],[@bib44]\]. To this end, mass spectrometric analysis of AGE-protein adducts from DHA-treated keratinocytes was performed ([Fig. 4](#fig4){ref-type="fig"}e) \[[@bib35]\]. Indeed, it was observed that DHA treatment induced posttranslational protein adduction as evident from up to five-fold elevated levels of specific AGEs known to result from triose-adduction of protein targets. Specifically, DHA-dependent formation of N^7^-(carboxyethyl)-[l]{.smallcaps}-arginine (CEA), (carboxyethyl)-[l]{.smallcaps}-lysine (CEL), and lactoyl-[l]{.smallcaps}-lysine was detectable in HaCaT keratinocytes exposed to concentrations as low as 10 mM, and the hydroimidazolone-type AGE MG-H1, derived from the DHA-oxidation product methylglyoxal, was detectable upon exposure to higher DHA concentrations (20 mM) \[[@bib45],[@bib46]\].

After substantiating the occurrence of DHA-induced glycation stress as assessed by AGE-formation, we explored the role of *GLO1* expression in determining DHA sensitivity displayed by cultured skin cells. *GLO1* is an essential glycation stress response gene encoding glyoxalase 1, an enzyme involved in the detoxification of the triose-derived glycolytic byproduct methylglyoxal. However, we noticed that acute DHA exposure \[performed in analogy to the mRNA expression array analysis as depicted above ([Fig. 2](#fig2){ref-type="fig"})\] did not cause significant changes in *GLO1* expression levels detected in HaCaT keratinocytes ([Fig. 4](#fig4){ref-type="fig"}f). Next, to further explore the potential role of *GLO1* expression in DHA sensitivity, we compared DHA cytotoxicity between isogenic cultured skin cells displaying differential *GLO1* expression levels as achieved by CRISPR/Cas9-engineering ([Fig. 4](#fig4){ref-type="fig"}g--i). To this end, human malignant melanoma (A375-*GLO1*\_WT versus KO) cells, generated and validated recently in our laboratory to study the impact of *GLO1* expression on melanoma invasiveness, were used to examine whether *GLO1* status would determine cellular DHA sensitivity. First, validation of KO status of these cells indicated that A375-*GLO1*\_KO (as compared to A375-*GLO1*\_WT) cells display loss of *GLO1* mRNA ([Fig. 4](#fig4){ref-type="fig"}g), immunoreactivity ([Fig. 4](#fig4){ref-type="fig"}g; insert), and enzymatic activity ([Fig. 4](#fig4){ref-type="fig"}h). It was then observed that A375-*GLO1*\_KO as compared to wildtype control cells displayed hypersensitivity to DHA-induced loss of viability as assessed by flow cytometric analysis ([Fig. 4](#fig4){ref-type="fig"}i). This differential hypersensitivity towards DHA exposure potentially attributable to *GLO1* deletion in these isogenic cell line variants was evident from detection of increased induction of cell death in response to DHA concentrations as low as 1 mM. Taken together, these data indicate that DHA treatment induces skin cell glycation stress as evident from AGE-formation in HaCaT keratinocytes and hypersensitivity to DHA-induced loss of viability displayed by genetically-engineered human malignant A375 melanoma cells that do not express the glycation stress defense gene *GLO1*.

In human epidermal reconstructs topical DHA induces a distinct stress response gene expression profile (different from that induced by exposure to solar UV) and AGE-formation with upregulation of stress response protein-phosphorylation (p-Hsp27).

Given the pronounced skin cell stress response induced by DHA detectable in cultured human keratinocytes, further experiments were performed that would test the possibility of similar responses in reconstructed fully differentiated human epidermis, an accepted organotypic model of human skin used widely for the toxicological assessment of topical treatments \[[@bib19],[@bib30], [@bib31], [@bib32]\]. Following exposure \[10% DHA in carrier (Vanicream™) versus carrier only\], it was observed that topical DHA caused pronounced epidermal yellowing (i.e. melanoidin-type pigmentation) in epidermal reconstructs detectable (within 24 h exposure) by visible inspection and colorimetric image analysis ([Fig. 5](#fig5){ref-type="fig"}a). Next, heat shock stress response gene expression \[as observed earlier in HaCaT keratinocytes exposed to DHA ([Fig. 2](#fig2){ref-type="fig"})\] was first examined by single RT-qPCR analysis indicating significant upregulation of *HSPA6* and *HSPA1A* observable at a 10 mM exposure level ([Fig. 5](#fig5){ref-type="fig"}b). Subsequently, epidermal stress response gene expression array profiling was executed ([Fig. 5](#fig5){ref-type="fig"}c and [Table 1](#tbl1){ref-type="table"}), performed in direct analogy to the analysis of DHA-exposed cultured human keratinocytes ([Fig. 2](#fig2){ref-type="fig"}a--c). Moreover, for comparison, epidermal stress response gene expression array analysis was performed in response to exposure to a supra-erythemal dose of solar simulated UV \[2 minimal erythemal doses (MEDs): 240 mJ/cm^2^ (UVB); 4.6 J/cm2 (UVA)\], an experimental design that would allow the identification of genes equally or differentially sensitive to either one of these relevant cutaneous stimuli, \[i.e, DHA ('sunless tanning') versus solar UV ('sun exposure-induced tanning')\] ([Fig. 5](#fig5){ref-type="fig"}d and [Table 1](#tbl1){ref-type="table"}) \[[@bib36]\]. These comparative gene expression data (DHA-versus UV-exposed epidermal reconstructs) are displayed in Venn-diagram depiction and also in numerical table format ([Fig. 5](#fig5){ref-type="fig"}e and [Table 1](#tbl1){ref-type="table"}, respectively).Fig. 5**Differential stress response gene expression analysis in human reconstructed epidermis exposed to topical DHA or acute solar simulated UV**. (a) After treatment \[DHA (10% in Vanicream™) versus carrier control; 24 h\], organotypic human epidermal reconstructs were imaged for colorimetric analysis; left: representative images; right: bar graph summarizing colorimetric values (mean ± SD). (b--c) After treatment \[DHA (10% in Vanicream™) versus carrier control; 6 h\], organotypic human epidermal reconstructs were analyzed for gene expression changes: (b) Individual RT-qPCR analysis (*HSPA1A*, *HSPA6*; mean ± SD; DHA: 1 or 10%). (c) Gene expression changes as determined using the Human Stress and Toxicity PathwayFinder™ PCR Array technology comparing DHA- and carrier-exposed epidermal reconstructs depicted as a volcano plot and summarized numerically in [Table 1 (d-e)](#tbl1){ref-type="table"} Comparative gene expression array analysis of solar simulated UV-exposed epidermal reconstructs \[240 mJ/cm^2^ UVB versus unexposed carrier control; 6 h after UV) displayed as a volcano plot (d), versus DHA (in Venn diagram depiction with total number of genes per group) (e), and summarized numerically in [Table 1](#tbl1){ref-type="table"}. (f) Immunohistochemical analysis of epidermal reconstructs \[prepared as in (a)\]. (g) Immunohistochemical analysis of SKH-1 mouse skin 3 d after treatment \[DHA (10% in Vanicream™) versus carrier control\].Fig. 5Table 1Comparative gene expression changes in human epidermal reconstructs (DHA versus UV) as performed and detected by Human Stress and Toxicity PathwayFinder™ PCR Array analysis specified in [Fig. 5](#fig5){ref-type="fig"}; all statistically significant changes detected in at least one treatment group are depicted (p \< 0.05).Table 1Gene symbolgene descriptionfold-change\[accession number\]UVDHA***CYP1A1*** \[NM_005260\]Cytochrome P450, family 1, subfamily A, polypeptide 148.58ns***CYP2E1*** \[NM_024013\]Cytochrome P450, family 2, subfamily E, polypeptide 17.19ns***HSPA1A*** \[NM_013371\]Heat shock 70 kDa protein 1A7.064.98***CCL21*** \[NM_000757\]Chemokine (C--C motif) ligand 216.99ns***CYP7A1*** \[NM_000605\]Cytochrome P450, family 7, subfamily A, polypeptide 16.99ns***FASLG*** \[NM_002187\]Fas ligand (TNF superfamily, member 6)6.991.95***IL6*** \[NM_000600\]Interleukin 6 (interferon, beta 2)ns6.35***CCL4*** \[NM_058186\]Chemokine (C--C motif) ligand 46.13ns***NOS2*** \[NM_000595\]Nitric oxide synthase 2, inducible5.68ns***UGT1A4*** \[NM_003807\]UDP glucuronosyltransferase 1 family, polypeptide A45.64ns***IL1B*** \[NM_000879\]Interleukin 1, beta4.67ns***HMOX1*** \[NM_022789\]Heme oxygenase (decycling) 14.60ns***CSF2*** \[NM_000557\]Colony stimulating factor 2 (granulocyte-macrophage)1.903.85***HSPA5*** \[NM_012275\]Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)3.76ns***DNAJA1*** \[NM_002170\]DnaJ (Hsp40) homolog, subfamily A, member 13.64ns***FMO1*** \[NM_002188\]Flavin containing monooxygenase 13.38ns***LTA*** \[NM_000880\]Lymphotoxin alpha (TNF superfamily, member 1)3.28ns***DNAJB4*** \[NM_002176\]DnaJ (Hsp40) homolog, subfamily B, member 43.02ns***HSPD1*** \[NM_018724\]Heat shock 60 kDa protein 1 (chaperonin)2.203.00***PCNA*** \[NM_002341\]Proliferating cell nuclear antigen2.775.25***DDIT3*** \[NM_002169\]DNA-damage-inducible transcript 3ns2.82***GSTM3*** \[NM_013278\]Glutathione S-transferase mu 3 (brain)2.75ns***HSPA2*** \[NM_000576\]Heat shock 70 kDa protein 22.61ns***HSPA6*** \[NM_014440\]Heat shock 70 kDa protein 6 (HSP70B′)2.465.30***HSPA8*** \[NM_173205\]Heat shock 70 kDa protein 82.44ns***TNFRSF1A*** \[NM_003809\]Tumor necrosis factor receptor superfamily, member 1A2.302.87***UNG*** \[NM_003326\]Uracil-DNA glycosylase2.27ns***MDM2*** \[NM_000584\]Mdm2 p53 binding protein homolog (mouse)2.25ns***CDKN1A*** \[NM_005811\]Cyclin-dependent kinase inhibitor 1A (p21, Cip1)2.12ns***XRCC2*** \[NM_001244\]X-ray repair complementing defective repair2.112.90***EGR1*** \[NM_020124\]Early growth response 1ns2.13***CHEK2*** \[NM_016204\]CHK2 checkpoint homolog (*S. pombe*)2.110.5***NFKB1*** \[NM_003240\]Nuclear factor of kappa light polypeptide gene enhancer2.07ns***GADD45A*** \[NM_000585\]Growth arrest and DNA-damage-inducible, alpha1.98ns***HSPE1*** \[NM_021803\]Heat shock 10 kDa protein 1 (chaperonin 10)2.001.98***ERCC1*** \[NM_000641\]Excision repair cross-complementing, complementation group 12.00ns***CASP10*** \[NM_001718\]Caspase 10, apoptosis-related cysteine peptidase0.580.5***ATM*** \[NM_001200\]Ataxia telangiectasia mutated0.50ns***HSP90AA2P*** \[NM_019618\]Heat shock protein 90 kDa alpha, class A member 20.49ns***HSPA1L*** \[NM_000575\]Heat shock 70 kDa protein 1-like0.49ns***CCNC*** \[NM_000639\]Cyclin C0.463.35***ANXA5*** \[NM_006129\]Annexin A50.44ns***CASP8*** \[NM_001719\]Caspase 8, apoptosis-related cysteine peptidase0.42ns***SERPINE1*** \[NM_000594\]Serpin peptidase inhibitor, clade E, member 10.41ns***TNFSF10*** \[NM_003808\]Tumor necrosis factor (ligand) superfamily, member 100.40ns***TNF*** \[NM_003701\]Tumor necrosis factor0.323.40***RAD50*** \[NM_003239\]RAD50 homolog (*S. cerevisiae*)0.22ns***CCL3*** \[NM_000758\]Chemokine (C--C motif) ligand 30.03ns***BCL2L1*** \[NM_130851\]BCL2-like 10.01ns

Strikingly, comparative gene expression array analysis revealed that only thirteen genes were jointly responsive to UV- and DHA-exposure ([Fig. 5](#fig5){ref-type="fig"}e and [Table 1](#tbl1){ref-type="table"}). The number of genes modulated exclusively by DHA exposure (a total of three only: *IL6*, *DDIT3*, *EGR1*) was much lower than the number of genes responsive exclusively responsive to UV (a total of thirty three) which included those encoding specific members of the cytochrome P450 family (e.g. *CYP1A1, CYP2E1, CYP7A1*) and also affecting inflammatory (*CCL21*, *CCL3*, *CCL4*, *IL1B*, *LTA*, *NOS2, TNFSF10*), heat shock (*DNAJA1*, *DNAJB4*, *HSPA2*, *HSPA5*, *HSPA8*, *HSPA1L*, *HSP90AA2P*), antioxidant (*GSTM3*, *HMOX1*), DNA damage (*ATM*, *ERCC1*, *GADD45A*, *RAD50*), proliferative (*CCNC*, *CDKN1A*), and cell survival (*ANXA5*, *BCL2L1*, *CASP8*, *FASLG*) control. These data allow to draw the conclusion that (at specific exposure levels examined in this limited prototype study), the transcriptional consequences and epidermal impact of solar UV-exposure far outweigh those imposed by DHA-exposure.

Interestingly, among the thirteen genes (*HSPA1A*, *FASLG*, *CSF2*, *HSPD1*, *PCNA*, *HSPA6*, *TNFRSF1A*, *XRCC2*, *CHEK2*, *HSPE1*, *CASP10*, *CCNC*, *TNF)* jointly responsive to either UV- or DHA-exposure, some expression changes imposed by UV (fold changes) quantitatively outweighed those imposed by DHA \[such as: *HSPA1A* (7- versus 5-fold upregulation), *FASLG* (7- versus 2-fold upregulation), respectively ([Table 1](#tbl1){ref-type="table"})\]. Vice versa, among these expression changes (responsive to both UV- or DHA-exposure), some DHA-induced alterations significantly outweighed those imposed by UV \[such as: *CSF2* (2- versus 4-fold upregulation), *PCNA* (3- versus 5-fold upregulation), *HSPA6* (3- versus 5-fold upregulation), *TNF* (0.3- versus 3-fold downregulation), respectively ([Table 1](#tbl1){ref-type="table"})\].

Next, immunohistochemical analysis was used to explore the consequences of DHA-treatment in epidermal reconstructs ([Fig. 5](#fig5){ref-type="fig"}f). Strikingly, as observed before in human keratinocytes ([Figs. 2](#fig2){ref-type="fig"}d and [3](#fig3){ref-type="fig"}), pronounced upregulation of DHA-induced staining for CEL, HO-1, total HSP27, and phospho-HSP27 (S78) was detected, indicative of glycation-stress-associated AGE-epitope formation and heat shock-related stress response signaling.

Likewise, to explore the possibility that similar responses are detectable in an *in vivo* exposure model, prototype experimentation was performed in hairless SKH-1 mouse skin treated with DHA ([Fig. 5](#fig5){ref-type="fig"}g). Indeed, immunohistochemical analysis revealed that DHA-exposed mouse skin displayed prominent epidermal staining for AGE-epitopes (CML/CEL), antioxidant markers (HO-1), and heat shock response \[total HSP27 and phospho-HSP27 (S78)\], changes reminiscent of immunohistochemical alterations observed in human epidermal reconstruct exposed to topical DHA. However, future experiments performed at the transcriptional and protein expression levels will have to be performed (using mouse and human skin) in order to further substantiate these prototype findings obtained in live murine skin exposed topically to DHA.

4. Discussion {#sec4}
=============

Since its accidental discovery almost 50 years ago, chemical tanning is widely regarded as a safe alternative to solar UV-induced skin tanning known to be associated with epidermal genotoxic stress, but the cutaneous biology impacted by sunless tanning that involves chemical reactions remains largely unexplored \[[@bib8], [@bib9], [@bib10], [@bib11]\]. Here, we have examined the cutaneous effects of acute DHA exposure employing cultured human keratinocytes and epidermal reconstructs, profiled by gene expression array analysis and immunodetection. In human HaCaT keratinocytes, DHA exposure (up to 20 mM; 6 h) did not impair viability while causing a pronounced cellular stress response as obvious from activation of phospho-protein signal transduction \[p-p38, p-Hsp27(S15/S78), p-eIF2α\] and gene expression changes (*HSPA6*, *HMOX1*, *CRYAB, CCL3*), both of which were not observed upon exposure to the non-ketose, tanning-inactive DHA-control glycerol. Likewise, a cosmetic use-relevant topical DHA dose-regimen elicited a pronounced transcriptional stress response observable in human epidermal reconstructs as revealed by gene expression array (*HSPA1A*, *HSPA6*, *HSPD1*, *IL6*, *DDIT3, EGR1*) and immunohistochemical analysis (CEL, HO-1, p-Hsp27-S78). Strikingly, in human epidermal reconstructs, DHA treatment, compared directly to the consequences of acute exposure to solar simulated light (delivered at approximately two MEDs), caused modulation of thirteen genes also responsive to solar UV. Strikingly, expression of only three genes was exclusively responsive to this chemical tanning agent, including *IL6* (encoding the pro-inflammatory cytokine 'interleukin-6'), *DDIT3* \[also known as *GADD153*, encoding the proteotoxic stress-response transcription factor 'C/EBP homologous protein' (CHOP)\], and *EGR1* (encoding the tumor protein p53-responsive stress transcription factor 'early growth response protein 1'), whereas a much higher number of genes (a total of thirty three, as assessed by array analysis) was responsive exclusively to solar UV, indicating that DHA treatment causes a more focused and limited gene expression pattern as compared to solar UV exposure.

Obviously, functional consequences of acute cellular and tissue responses elicited by topical DHA exposure, profiled for the first time in this prototype study in cultured human keratinocytes and epidermal reconstructs, remain largely unexplored and must be validated and expanded in adequate follow up studies using relevant exposure regimens, preferably performed in live human skin *ex vivo* and *in vivo* \[[@bib6],[@bib8],[@bib12],[@bib14]\]. Likewise, more detailed cutaneous pharmacokinetic and pharmacodynamic exploration must be performed, examining effects of DHA and related chemical tanning agents (applied in commercially relevant formulations and vehicles including spray tan applications) as encountered in consumer products used worldwide, with inclusion of adequate vehicle controls that represent these often complex formulations optimized for epidermal delivery and residence time \[[@bib8],[@bib12]\].

Given the significant epidermal changes that occur in response to DHA exposure impacting stress response gene expression and phosphoprotein signaling, it is tempting to speculate that these changes might also engage in molecular cross-talk with established environmental cutaneous stressors (including solar UV, ozone, arsenic, particulate matter etc.), potentially synergizing with or even attenuating inflammatory, genotoxic, glycoxidative, redox, and proteotoxic impact of these environmental stressors, relevant to skin barrier function, aging, carcinogenesis, and other determinants of skin health \[[@bib6],[@bib15],[@bib19],[@bib44],[@bib47], [@bib48], [@bib49], [@bib50]\]. Moreover, sunless skin tanning through glycation reactions is also known to provide a moderate sun protection factor thought to originate from UV-absorptivity of melanoidin pigments, and it will be interesting to probe if DHA-induced photoprotection might also be attributable to modulation of stress response pathways as reported here for the first time \[[@bib51]\].

The role of glycation stress associated with sunless tanning using reactive triose and tetrose sugars (including DHA and erythrulose, respectively), imposed by enabling epidermal glycation reactions that cause formation of melanoidin-pigments mimicking solar UV-induced melanogenesis, remains to be explored in much detail \[[@bib20]\]. In our prototype study, formation of DHA-derived AGEs resulting from posttranslational protein adduction was confirmed by quantitative mass spectrometric detection of N^ε^-(carboxyethyl)-[l]{.smallcaps}-lysine (CEL) and *N*^7^-carboxyethyl-[l]{.smallcaps}-arginine (CEA) in HaCaT keratinocytes as well as CEL-immunodetection performed in human epidermal reconstructs and mouse skin. In this context, it will be interesting to explore the specific identity of molecular targets undergoing glycation by DHA upstream of stress response signaling and gene expression. Moreover, it might be speculated that glycation-active glycolytic intermediates formed from cellular energy metabolism, such as dihydroxyacetone phosphate (and methylglyoxal derived thereof), might elicit cellular stress responses similar to those detected by us in response to exogenous DHA \[[@bib13],[@bib46],[@bib52]\]. Likewise, the role of the intrinsic cellular glycation defense attenuating glycation damage deserves further examination, as evidenced by our observation that A375 melanoma cells with genetic *GLO1* deletion display hypersensitivity towards DHA, focusing on the potential cytoprotective role of *GLO1* expression in cutaneous keratinocytes and intact human skin \[[@bib29],[@bib40],[@bib53]\]. Interestingly, DHA-dependent induction of cell death observable in cultured malignant melanoma cells has been reported before, but the potential therapeutic implication of this observation remains to be substantiated \[[@bib40]\]. Importantly, glycation stress has long been known to impact structural integrity of major skin components such as collagens and elastins, relevant to the occurrence of increased glycoxidative skin damage observable in diabetic patients, but the occurrence of similar changes in response to chemical tanning through topical application of glycation-active ingredients might largely depend on specific skin pharmacokinetic profile of these agents and formulations \[[@bib15],[@bib19],[@bib44]\]. It has now been demonstrated that AGEs, serving as damage-associated molecular patterns (DAMPs) that form in response to electrophilic environmental stressors, are also recognized by specialized receptors including RAGE and TLR4, widely expressed throughout skin and known to be involved in innate immunity, inflammatory remodeling, and even tumorigenic progression (as demonstrated for RAGE-dependent melanoma cell invasion and metastasis) \[[@bib20],[@bib24], [@bib25], [@bib26]\]. Finally, a role of AGEs as cutaneous photosensitizers and mediators of skin photooxidative stress, activated by solar UVA and blue light excitation, has recently been substantiated, and it remains to be seen if DHA-derived cutaneous AGEs might serve a similar function \[[@bib17],[@bib23],[@bib47]\].

Taken together, these prototype data profile for the first time a comprehensive DHA-induced acute epidermal stress response at the transcriptional level that profoundly differs from that elicited by solar UV exposure, a finding that deserves further molecular exploration in living human skin \[[@bib5]\]. Molecular pathways that may facilitate sunless tanning and skin pigmentation are of much interest in the context of both, therapeutic intervention targeting dyspigmentation pathologies such as vitiligo and cosmetic intervention facilitating skin tanning in the absence of UV-induced genotoxic stress \[[@bib1],[@bib5],[@bib6],[@bib8],[@bib54]\]. Given the worldwide use of DHA in consumer products accentuated by a growing interest in safer molecular approaches that allow sunless tanning without compromising skin barrier and function, these prototype data may provide a first framework for future mechanistic studies.
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